secwatch.observer — SEC 8-K summary
======================================

Issuer:     Roivant Sciences Ltd. (ROIV)
CIK:        0001635088
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001193125-21-288885
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 3.02, 3.03, 5.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Roivant Sciences closes SPAC merger with MAAC; trading starts Oct 1 on Nasdaq under ROIV
--------------------------------------------------------------------------------

- Post-close cash ~$2.5B; PIPE raised $220M from 22M shares at $10.00 each.
- Richard Pulik appointed CFO effective Sept 28, replacing Matt Gline who remains CEO; Pulik from Novartis.
- Pulik receives $400K salary, target 100% bonus, 220,015 RSUs, and options for 313,419 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635088/000119312521288885/0001193125-21-288885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635088/000119312521288885/d230641d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-288885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer